Suchergebnisse - "Spiekermann, Karsten"

PubPharm (15)

11

JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

enthalten in: Leukemia | 2019

von Lynch, J. | Salik, B. | Connerty, P. | +13

12

KIT D816 mutated/CBF-negative acute myeloid leukemia : a poor-risk subtype associated with systemic mastocytosis

enthalten in: Leukemia | 2019

von Jawhar, M. | Döhner, K. | Kreil, S. | +23

CommentIn: Leukemia. 2021 Jan;35(1):282-285. - PMID 33106623

13

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

sonderdruck aus: Leukemia | 2019

von Jawhar, M. | Döhner, K. | Kreil, S. | +23

14

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study

enthalten in: Leukemia | 2018

von Braess, J. | Amler, S. | Kreuzer, K. | +43

15

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

enthalten in: Leukemia | 2018

von Rothenberg-Thurley, M. | Amler, S. | Goerlich, D. | +15